SeeSAR is your intuitive, visual drug design platform. Covering every step of your drug discovery process — from virtual screening to fragment-based design — SeeSAR fosters ideation in the most fun and comprehensive way.

infiniSee

infiniSee is your Chemical Space navigation platform. Based on similarity, infiniSee finds molecules of interest in screening libraries or Chemical Spaces of almost infinite size. Given a template or query molecule, infiniSee returns unexpectedly similar molecules.

This website uses cookies so that we can provide the best service possible. Get more information from our privacy policy.

Essential

Auto Sign In

Statistics

Accept selected

Accept all

Avergen and BioSolveIT backed by PERMIDES grant for personalized medicine

Avergen and BioSolveIT backed by PERMIDES grant for personalized medicine

July 25, 2017 14:29 CEST

BioSolveIT and Avergen win a prestigious PERMIDES grant from the European Union to fight against cancer exploiting protein-protein interaction inhibition.

Read the full press release here:
www.biosolveit.de/press/archive/2017-07-25_Avergen.html